Hepatopulmonary syndrome and extrahepatic vascular abnormalities
Michael J. Krowka – 30 December 2003
Liver transplantation in Eastern Europe
Julius Špicák, Štefan Vítko, Miroslav Ryska, Pavel Trunecka, František Belina, Marek Krawczyk, Ferenc Perner, Pavel Taimr, Jan Šperl, Halima Hrncárková, Jan Peregrín, Helena Filipová, Karel Filip – 30 December 2003 – The aim of this report is to evaluate the development of liver transplantation in eastern Europe until mid‐1998. Representatives of gastroenterological and hepatological societies of the respective countries answered a questionnaire about the most descriptive items of the issue of liver transplantation.
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation
S. Forrest Dodson, Michael E. de Vera, C. Andrew Bonham, David A. Geller, Jorge Rakela, John J. Fung – 30 December 2003 – The prevention of recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) with hepatitis B immunoglobulin (HBIG) is expensive and requires indefinite parenteral administration. Lamivudine is a nucleoside analogue capable of inhibiting HBV replication.
Split‐liver transplantation for adult recipients
Amadeo Marcos – 30 December 2003
Liver transplantation for alcoholic liver disease: Bias, beliefs, 6‐month rule, and relapse—but where are the data?
Thomas P. Beresford, Gregory T. Everson – 30 December 2003
Surgery and transplantation for hepatocellular cancer
William J. Wall, Paul J. Marotta – 30 December 2003 – Key Points
Acute rejection of hepatic allografts from HLA‐DR13 (Allele DRB1*1301)‐positive donors
Michael Oertel, Frieder Berr, Sabine Schröder, Rene Schwarz, Andrea Tannapfel, Michael Wenzke, Peter Lamesch, Johann Hauss, Kay Kohlhaw – 30 December 2003 – Acute rejection of hepatic allografts does not show consistent association with the number of mismatches of HLA classes I and II. Therefore, we investigated the relation between specific donor or recipient HLA antigens and the occurrence of acute rejection.
Histoplasmosis in an explant liver with subsequent seeding of the liver allograft
Pamela B. Sylvestre, Alvaro R. Gonzalez‐Koch, Michael B. Ishitani – 30 December 2003
Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging
Nadim Joni Shah, Heiko Neeb, Maxim Zaitsev, Sven Steinhoff, Gerald Kircheis, Katrin Amunts, Dieter Häussinger, Karl Zilles – 30 December 2003 – Changes are shown in the spin‐lattice (T1) relaxation time caused by the putative deposition of manganese in various brain regions of hepatic encephalopathy (HE) patients using a novel and fast magnetic resonance imaging (MRI) method for quantitative relaxation time mapping. A new method, T1 mapping with partial inversion recovery (TAPIR), was used to obtain a series of T1‐weighted images to produce T1 maps.
Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo
Hiroyasu Ito, Kazuki Ando, Toshinori Nakayama, Masaru Taniguchi, Takayuki Ezaki, Kuniaki Saito, Masao Takemura, Kenji Sekikawa, Michio Imawari, Mitsuru Seishima, Hisataka Moriwaki – 30 December 2003 – Although we have previously demonstrated that IL‐12 stimulation increases the number of hepatic natural killer (NK) T (NKT) cells and enhances liver injury during the early phase of liver regeneration, the role of NKT cells has remained unknown.